Mylan And Biocon Says EMA Accept Its Regulatory Submission Of Biosimilar Pegfilgrastim
July 21, 2016 at 12:31 PM EDT
Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. revealed that the European Medicines Agency (EMA) has accepted their Marketing Authorization ...